Monday, September 28, 2020

β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology

https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-020-01948-5

No comments:

Post a Comment